These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Management of keloids and hypertrophic scars. Juckett G; Hartman-Adams H Am Fam Physician; 2009 Aug; 80(3):253-60. PubMed ID: 19621835 [TBL] [Abstract][Full Text] [Related]
23. Medical and surgical management of keloids: a review. Shockman S; Paghdal KV; Cohen G J Drugs Dermatol; 2010 Oct; 9(10):1249-57. PubMed ID: 20941950 [TBL] [Abstract][Full Text] [Related]
24. Hypertrophic scars and keloids: a recurrent problem revisited. Ellitsgaard V; Ellitsgaard N Acta Chir Plast; 1997; 39(3):69-77. PubMed ID: 9439007 [TBL] [Abstract][Full Text] [Related]
25. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Tredget EE; Nedelec B; Scott PG; Ghahary A Surg Clin North Am; 1997 Jun; 77(3):701-30. PubMed ID: 9194888 [TBL] [Abstract][Full Text] [Related]
26. Biologic basis for the treatment of keloids and hypertrophic scars. Peacock EE; Madden JW; Trier WC South Med J; 1970 Jul; 63(7):755-60. PubMed ID: 5427162 [No Abstract] [Full Text] [Related]
27. Immunohistochemical Evaluation of Leptin Expression in Wound Healing: A Clue to Exuberant Scar Formation. Seleit I; Bakry OA; Samaka RM; Tawfik AS Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):296-306. PubMed ID: 26258753 [TBL] [Abstract][Full Text] [Related]
28. Keloids: an update on medical and surgical treatments. Love PB; Kundu RV J Drugs Dermatol; 2013 Apr; 12(4):403-9. PubMed ID: 23652887 [TBL] [Abstract][Full Text] [Related]
31. The pathogenesis of hypertrophic/keloid scarring. Thomas DW; Hopkinson I; Harding KG; Shepherd JP Int J Oral Maxillofac Surg; 1994 Aug; 23(4):232-6. PubMed ID: 7798696 [TBL] [Abstract][Full Text] [Related]
32. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis. Ogawa R Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424 [TBL] [Abstract][Full Text] [Related]
33. Observational retrospective study evaluating the effects of oral isotretinoin in keloids and hypertrophic scars. Guadanhim LR; Gonçalves RG; Bagatin E Int J Dermatol; 2016 Nov; 55(11):1255-1258. PubMed ID: 27419807 [TBL] [Abstract][Full Text] [Related]
34. Keloid management and its present status. Doyle DE; Passey V Eye Ear Nose Throat Mon; 1975 Jun; 54(6):239-43. PubMed ID: 1092556 [No Abstract] [Full Text] [Related]
35. Molecular dissection of abnormal wound healing processes resulting in keloid disease. Shih B; Garside E; McGrouther DA; Bayat A Wound Repair Regen; 2010; 18(2):139-53. PubMed ID: 20002895 [TBL] [Abstract][Full Text] [Related]
36. Scarring and wound healing. Potter DA; Veitch D; Johnston GA Br J Hosp Med (Lond); 2019 Nov; 80(11):C166-C171. PubMed ID: 31707882 [TBL] [Abstract][Full Text] [Related]
39. Keloids in the African. Oluwasanmi JO Clin Plast Surg; 1974 Jan; 1(1):179-95. PubMed ID: 4609662 [No Abstract] [Full Text] [Related]
40. Management of keloids and hypertrophic scars. Tritto M; Kanat IO J Am Podiatr Med Assoc; 1991 Nov; 81(11):601-5. PubMed ID: 1784016 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]